Is inspiratory muscle training (IMT) an acceptable treatment option for people with chronic obstructive pulmonary disease (COPD) who have declined pulmonary rehabilitation (PR) and can IMT enhance PR uptake? A single-group prepost feasibility study in a home-based setting. Issue 8 (8th August 2019)

• Record Type: Journal Article
• Authors: O'Connor, Cath; Lawson, Rod; Waterhouse, Judith; Mills, Gary H
• Is Part Of: BMJ open. Volume 9:Issue 8(2019)
• Publication Date: 2019-08-08
• Subjects: chronic airways disease -- pulmonary rehabilitation -- inspiratory muscle training -- adherence -- rehabilitation medicine -- uptake; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2018-028507
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Objectives: This feasibility study aimed to assess the acceptability of inspiratory muscle training (IMT) in people with chronic obstructive pulmonary disease (COPD) who declined pulmonary rehabilitation (PR) as a potential treatment option or precursor to PR. Objectives were to assess attitudes to IMT, PR and alternatives to PR; factors influencing adherence with IMT and acceptability of outcome measures, research tools and study protocol. Design: A pragmatic, mixed methods, prepost feasibility study was conducted. Recruitment took place over a 4-month period. Participants were followed up for a period of 6 months. Settings: IMT sessions and assessments were conducted in the domiciliary setting. Participants: Inclusion criteria: people over the age of 35, stable COPD, Medical Research Council Dyspnoea scale of 3 or above, declined PR. Exclusion criteria: history of spontaneous pneumothorax, incomplete recovery from a traumatic pneumothorax, asthma, known recently perforated eardrum, unstable angina, ventricular dysrhythmias, cerebrovascular event or myocardial infarction within the last 2 months. Participants were selected from a purposive sample. Of the 22 potential participants screened, 11 were recruited and interviewed. Ten participants commenced IMT. Seven participants completed the follow-up assessment. Intervention: Eight weeks of IMT twice a day, 5 days a week with visits once weekly by a physiotherapist. Unsupervised IMT twice a day three times a week until follow-up at 6 months. Outcomes: Acceptability of IMT and the study process was explored via semi-structured interviews. Adherence with IMT was assessed by the Powerbreathe K3 device and participant diaries. Uptake of PR was identified. Results: IMT was found to be acceptable. Adherence was explored. Four people went on to participate in PR. Conclusions: Feasibility was established. A randomised controlled trial is warranted to establish efficacy and cost-effectiveness of IMT in those who decline PR and IMT as an intervention to promote uptake of PR. Trial registration number: NCT01956565 ; Post-results.